Abstract
Eighteen patients with measurable or evaluable lesions from squamous cancer of the esophagus received a regimen combining four active agents on an outpatient basis. Nine of 14 evaluable patients (64%, or 50% of 18 patients entered) responded: four of five with previously untreated regional disease and five of nine with recurrent or metastatic disease. Median duration of response in the latter group was 5 months (longest response, 13). Treatment was well-tolerated in all patients but one, who developed signs of severe methotrexate toxicity and died of sepsis.
Original language | English (US) |
---|---|
Pages (from-to) | 21-23 |
Number of pages | 3 |
Journal | Cancer Treatment Reports |
Volume | 69 |
Issue number | 1 |
State | Published - 1985 |
ASJC Scopus subject areas
- Oncology
- Cancer Research